In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
President Vladimir Putin on Thursday ordered a ceasefire in Ukraine from 6 to 7 January. However,
Russian President Vladimir Putin announced on Thursday night that his army will not attack Ukrain
After winning the ICC Champions Trophy for the third time by defeating New Zealand by four wicket
The Ministry of Home Affairs has decided to provide a 10% reservation for Agniveers for recruitme
'China-Pakistan old friend, it started during Nehru'... Natwar Singh reminds Rahul of history
Congress leader Rahul Gandhi on Wednesday questioned the Modi government over the closeness betwe
US President Donald Trump is taking strict action against illegal immigration. The Trump administ
His coach also has a big hand during the performance of Rahul Teotia, who became the hero after s
Many states of North India including the capital Delhi are battling a severe heatwave these days.
If there is one thing that is being discussed the most at the Oscars this time, it is Will Smith'
Turkey will provide technical help for the operation of Kabul airport, Taliban appealed
Turkey has accepted the appeal of the Taliban in which Turkey was asked for technical help for th
